Improvement of spontaneous locomotor activity with JAK inhibition by JTE-052 in rat adjuvant-induced arthritis
Autor: | Yukari Kimoto, Wataru Amano, Keisuke Nozawa, Akira Matsuo, Yuichi Shinozaki, Atsuo Tanimoto, Takayuki Yamaguchi, Mutsuyoshi Matsushita |
---|---|
Jazyk: | angličtina |
Předmět: |
musculoskeletal diseases
Quality of life Male medicine.medical_specialty Pain-related behavior Time Factors JTE-052 Freund's Adjuvant Anti-Inflammatory Agents Arthritis Administration Oral Inflammation Pharmacology JAK inhibition Motor Activity Locomotor activity Drug Administration Schedule Rheumatology Internal medicine medicine Animals Orthopedics and Sports Medicine Rheumatoid arthritis Motor function Protein Kinase Inhibitors Janus Kinases Spontaneous locomotor activity Behavior Animal Dose-Response Relationship Drug business.industry Interleukin-6 Rodent model medicine.disease Adjuvant-induced arthritis Arthritis Experimental Adjuvant induced arthritis Surgery Hyperalgesia Rats Inbred Lew Joints medicine.symptom Inflammation Mediators business Janus kinase Biomarkers Research Article Signal Transduction |
Zdroj: | BMC Musculoskeletal Disorders |
ISSN: | 1471-2474 |
DOI: | 10.1186/s12891-015-0802-0 |
Popis: | Background Rheumatoid arthritis (RA) is a chronic inflammatory disease that leads to joint destruction, disability, and decreased quality of life (QOL). Inhibition of Janus kinase (JAK) signaling ameliorates articular inflammation and joint destruction in animal models of RA, but its effects on behaviors indicating well-being are poorly understood. In this study, we evaluated the effect of JAK inhibition on spontaneous locomotor activity in rats with adjuvant-induced arthritis, a rodent model of RA. Methods Arthritis was induced in male Lewis rats by a single subcutaneous injection of Freund’s complete adjuvant. The novel JAK inhibitor JTE-052 was orally administered for 7 days after the onset of arthritis. Results Induction of arthritis suppressed the spontaneous locomotor activity of the rats. Administration of JTE-052 completely improved the spontaneous locomotor activity, with partial reductions in articular inflammation and joint destruction. Hyperalgesia and motor functions were also improved, but the efficacy was not complete. However, serum interleukin (IL)-6 levels were completely decreased at 4 h after administration of the first dose of JTE-052. Conclusions This study demonstrated that JAK inhibition improved the spontaneous locomotor activity of rats with adjuvant-induced arthritis, in association with amelioration of pain and physical dysfunction as a consequence of suppression of joint inflammation. Moreover, although further studies are needed, there was possible participation of IL-6 downregulation in the improvement of locomotor activity by JAK inhibition. |
Databáze: | OpenAIRE |
Externí odkaz: |